
Results 1 - 20 of 2,287 in Schizophrenia
Long-lasting Zyprexa gets FDA nod
... its own patent and is expected to help the Indianapolis drug maker hang onto part of Zyprexa's sales after the schizophrenia pill's main patent expires in 2011 and generics move in to seize most of its market. The long-lasting product, called ... Comment?
www.PicksThatMove.com: "Picks that move" Alerts, December 14, 2009: LLY, BA, CAMD, HPQ and NITE
December 14, 2009 Eli Lilly and Company trading at $35.74 on a volume of 2.91M shares In a press release on December 14, FDA Approves Lilly's ZYPREXA RELPREVV for Treatment of Schizophrenia in Adults Long-acting injection provides therapeutic olanzapine exposure for up to four weeks INDIANAPOLIS, Dec 14, 2009 The U.S. Food and Drug Administration ... Comment?
Zyprexa Relprevv , a long-acting version of the antipsychotic drug Zyprexa, has been approved to treat schizophrenia in adults, maker Eli Lilly said Monday. Comment?
Japan approves Elan nanocrystal drug
w/Photo
... ements for EDT. In August, Janssen-Cilag announced that the FDA had approved its Invega Sustenna treatment for schizophrenia in the US. Comment?
FDA approves long-lasting version of Zyprexa
The Food and Drug Administration has approved a long-acting version of Eli Lilly's blockbuster anti-psychotic drug Zyprexa for the treatment of schizophrenia. Comment?
Early Treatment of Hearing, Vision Helps in Schizophrenia
Identifying sight and hearing problems in teens who are in the early stages of schizophrenia may help doctors fully restore those senses and lessen the impact of the devastating thought disorder, U.S. researchers say. Comment?
Swiss biotech Addex makes first profit, shares rise
... to upfront payments of $22 million from Merck for the license rights for Addex's ADX63365 drug for treating schizophrenia. That compared with a net loss of 19.5 million francs in the year-ago period. "Addex delivered as expected a strong H1 2008," ... Comment?
FDA OKs longer-lasting version of Lilly's Zyprexa
... Administration approved Zyprexa Relprevv, an injection that can last up to four weeks, for the treatment of schizophrenia in adults. Patients on Zyprexa currently take a pill daily. Lilly also makes a fast-acting injection of the drug that can be ... Comment?
Lilly wins approval for long-acting Zyprexa
... muscles, lasts up to four weeks. The U.S. Food and Drug Adminstration OK'd the long-acting version to treat schizophrenia. The drug could bring some much-needed profit to Lilly. The Indianapolis-based drugmaker will lose most of the $4.7 billion a ... Comment?
Study Shows That Poor Children are Likelier to Get Antipsychotic Medications
... who are covered by Medicaid. The F.D.A. has approved antipsychotic drugs for children specifically to treat schizophrenia, autism and bipolar disorder. But they are more frequently prescribed to children for other, less extreme conditions, including ... Comment?
FDA approves injected form of Zyprexa Relprevv
... at risk of relapse. The new drug is designed to break the a oerevolving doora cycle often associated with schizophrenia by allowing doctors to keep track of when patients have received their medication and immediately detect non-adherence when ... Comment?
FDA Approves Eli Lilly and Company's ZYPREXA(R) RELPREVV(TM) for...
The U.S. Food and Drug Administration approved ZYPREXA RELPREVV For Extended Release Injectable Suspension for the treatment of schizophrenia in adults, Eli Lilly and Company announced today. Comment?
... for conditions such as epilepsy. An example of this is Gabapentin, also called Neurontin. "Patient with schizophrenia and tardive dyskinesia developed bilateral corneal edema while receiving chronic amantadine hydrochloride." (1) After reading this ... Comment?
New biosensors show how drugs used to treat schizophrenia work
London, Dec 14 : New biosensors developed by researchers from the University of California, San Diego have successfully shown how a popular class of drugs used to treat schizophrenia works. Comment?
FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults
The FDA has approved ZYPREXA RELPREVV For Extended Release Injectable Suspension for the treatment of schizophrenia in adults, Eli Lilly and Company announced today. Comment?
Zyprexa Relprevv approved by Fda
The U.S. Food and Drug Administration approved ZYPREXA RELPREVV For Extended Release Injectable Suspension for the treatment of schizophrenia in adults, Eli Lilly and Company announced today. Comment?
Biosensors Reveal Workings Of Anti-Psychotic Drugs
Scientists have resolved a question about how a popular class of drugs used to treat schizophrenia works using biosensors that reveal previously hidden components of chemical communication in the brain. Comment?
New biosensors show how schizophrenic drugs alter brain chemistry
Scientists have resolved a question about how a popular class of drugs used to treat schizophrenia works using biosensors that reveal previously hidden components of chemical communication in the brain. Comment?
New biosensors reveal workings of anti-psychotic drugs in the living brain
Scientists have resolved a question about how a popular class of drugs used to treat schizophrenia works using biosensors that reveal previously hidden components of chemical communication in the brain. Comment?
Targacept pursues schizophrenia drug
Targacept has initiated a Phase 2 clinical trial of a drug it calls TC-5619 as a potential treatment for cognitive dysfunction in schizophrenia, according to an announcement. Comment?